Cytokine refacing effect reduces granulocyte macrophage colony-stimulating factor susceptibility to antibody neutralization.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25855658)

Published in Protein Eng Des Sel on April 07, 2015

Authors

Pete Heinzelman1, Sharon J Carlson2, George N Cox2

Author Affiliations

1: Department of Chemical, Biological & Materials Engineering, University of Oklahoma, Sarkeys Energy Center, 100 East Boyd Street, Room T-301, Norman, OK 73019, USA proteinpete@gmail.com.
2: Bolder Biotechnology, Boulder, CO 80301, USA.

Articles cited by this

Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects. Blood (2009) 2.79

Yeast surface display for protein engineering and characterization. Curr Opin Struct Biol (2007) 2.38

Sargramostim for active Crohn's disease. N Engl J Med (2005) 2.24

Rational cytokine design for increased lifetime and enhanced potency using pH-activated "histidine switching". Nat Biotechnol (2002) 2.09

The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell (2008) 1.83

Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Gastroenterology (2008) 1.35

Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis (2011) 1.33

Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis. Inflamm Bowel Dis (2008) 1.28

Reengineering granulocyte colony-stimulating factor for enhanced stability. J Biol Chem (2001) 1.01

Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease. Inflamm Bowel Dis (2013) 0.96

Interleukin-2 mutants with enhanced alpha-receptor subunit binding affinity. Protein Eng (2003) 0.95

Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor. Bioconjug Chem (2005) 0.94

The economic and quality-of-life burden of Crohn's disease in Europe and the United States, 2000 to 2013: a systematic review. Dig Dis Sci (2014) 0.89

Characterization of pathogenic human monoclonal autoantibodies against GM-CSF. Proc Natl Acad Sci U S A (2013) 0.88

A simplified method for the efficient refolding and purification of recombinant human GM-CSF. PLoS One (2012) 0.85

The structure and dynamics of the granulocyte macrophage colony-stimulating factor receptor defined by the ternary complex model. J Biol Chem (1993) 0.83

Slow-dissociation effect of common signaling subunit beta c on IL5 and GM-CSF receptor assembly. Cytokine (2008) 0.82

Sargramostim (GM-CSF) for induction of remission in Crohn's disease. Cochrane Database Syst Rev (2011) 0.81

Kinetic analysis of receptor-mediated endocytosis of G-CSF derivative, nartograstim, in rat bone marrow cells. Am J Physiol (1996) 0.78

Engineering superactive granulocyte macrophage colony-stimulating factor transferrin fusion proteins as orally-delivered candidate agents for treating neurodegenerative disease. Biotechnol Prog (2015) 0.78